Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 8—August 2009

Research

Increase in Pneumococcus Macrolide Resistance, United States

Stephen G. JenkinsComments to Author  and David J. Farrell
Author affiliations: Weill Cornell Medical College, New York, NY, USA (S.G. Jenkins); Quotient Bioresearch Ltd, London, UK (D.J. Farrell)

Main Article

Figure 2

Increased prevalence in the erm(B) + mef(A) macrolide resistance genotype from year 1 (2000–2001) to year 6 (2005−2006), Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin, United States surveillance study.

Figure 2. . Increased prevalence in the erm(B) + mef(A) macrolide resistance genotype from year 1 (2000–2001) to year 6 (2005−2006), Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin, United States surveillance study.

Main Article

TOP